Endotrophin and von Willebrand factor processing as predictive markers for mortality in the ECLIPSE COPD cohort
J. Sand (Herlev, Denmark), S. Rønnow (Herlev, Denmark), N. Gudmann (Herlev, Denmark), L. Langholm (Herlev, Denmark), M. Karsdal (Herlev, Denmark), T. Manon-Jensen (Herlev, Denmark), R. Tal-Singer (Collegeville, PA, United States of America), B. Miller (Collegeville, PA, United States of America), J. Vestbo (Manchester, United Kingdom), D. Leeming (Herlev, Denmark)
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Session: Evaluation of basic science in airway diseases
Session type: Poster Discussion
Number: 1716
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Sand (Herlev, Denmark), S. Rønnow (Herlev, Denmark), N. Gudmann (Herlev, Denmark), L. Langholm (Herlev, Denmark), M. Karsdal (Herlev, Denmark), T. Manon-Jensen (Herlev, Denmark), R. Tal-Singer (Collegeville, PA, United States of America), B. Miller (Collegeville, PA, United States of America), J. Vestbo (Manchester, United Kingdom), D. Leeming (Herlev, Denmark). Endotrophin and von Willebrand factor processing as predictive markers for mortality in the ECLIPSE COPD cohort. 1716
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Microalbuminuria and von Willebrand factor antigen (vWF) as markers of endothelial dysfunction in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 123s Year: 2004
Changes of plasma von Willebrand factor in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007
Diagnostic value of Von Willebrand factor (VWF) in patients suffering from respiratory distress Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011
Expression of CD 34 and von Willebrand factor in pulmonary endothelium Source: Eur Respir J 2001; 18: Suppl. 33, 243s Year: 2001
Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes}, Source: Eur Respir J 2012; 40: 657-664 Year: 2012
Endothelial injury in COPD assessed by microalbuminuria (MAB) and von Willebrand factor levels (vWf:Ag) and activity (vWf:Ac) Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Unusually large von Willebrand factor multimers might be involved in cardiovascular events in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
Response of plasma von Willebrand factor to systemic endothelial injury in pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 545s Year: 2006
Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020
PP220 – Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: ERS Lung Science Conference 2021 Year: 2021
A combination of biomarkers for fibrinolysis and basement membrane destruction predicts mortality in the ECLIPSE COPD cohort Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020
Risk factor biomarker differences in rehospitalization for patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 838s Year: 2006
Prognostic nutritional index (PNI): A predictive factor for elderly patients with COPD Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020
External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020
Endothelin, endothelial cells and von Willenbrandt factor in peripheral blood in asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 77s Year: 2003
Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019 Year: 2019
Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005
Predictive factors of mortality in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 76s Year: 2007
Blood biomarkers in COPD: results from the ECLIPSE (evaluation of COPD longitudinally to identify predictive surrogate endpoints) cohort Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009